SE451330B - Farmaceutisk komposition innefattande en antibiotisk substans benemnd bn-183b vilken er framstelld genom odling av pseudomonas sp bn-183 (ferm-p 3332,atcc 31571) - Google Patents

Farmaceutisk komposition innefattande en antibiotisk substans benemnd bn-183b vilken er framstelld genom odling av pseudomonas sp bn-183 (ferm-p 3332,atcc 31571)

Info

Publication number
SE451330B
SE451330B SE7910626A SE7910626A SE451330B SE 451330 B SE451330 B SE 451330B SE 7910626 A SE7910626 A SE 7910626A SE 7910626 A SE7910626 A SE 7910626A SE 451330 B SE451330 B SE 451330B
Authority
SE
Sweden
Prior art keywords
water
substance
acetic acid
absorption spectrum
ferm
Prior art date
Application number
SE7910626A
Other languages
English (en)
Swedish (sv)
Other versions
SE7910626L (sv
Inventor
N Ezaki
S Miyadoh
Y Ogawa
T Hisamatsu
H Fukuyashu
Y Yamada
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Publication of SE7910626L publication Critical patent/SE7910626L/xx
Publication of SE451330B publication Critical patent/SE451330B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE7910626A 1978-12-27 1979-12-21 Farmaceutisk komposition innefattande en antibiotisk substans benemnd bn-183b vilken er framstelld genom odling av pseudomonas sp bn-183 (ferm-p 3332,atcc 31571) SE451330B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15982078A JPS55102596A (en) 1978-12-27 1978-12-27 Novel antibiotic substance, bn-183b substance, and its preparation

Publications (2)

Publication Number Publication Date
SE7910626L SE7910626L (sv) 1980-06-28
SE451330B true SE451330B (sv) 1987-09-28

Family

ID=15701955

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7910626A SE451330B (sv) 1978-12-27 1979-12-21 Farmaceutisk komposition innefattande en antibiotisk substans benemnd bn-183b vilken er framstelld genom odling av pseudomonas sp bn-183 (ferm-p 3332,atcc 31571)

Country Status (14)

Country Link
US (1) US4283389A (fr)
JP (1) JPS55102596A (fr)
BE (1) BE880850A (fr)
CA (1) CA1133409A (fr)
CH (1) CH642397A5 (fr)
DE (1) DE2950980C2 (fr)
ES (1) ES487313A0 (fr)
FR (1) FR2445339A1 (fr)
GB (1) GB2039881B (fr)
IL (1) IL58964A (fr)
IT (1) IT1162430B (fr)
NL (1) NL178265C (fr)
SE (1) SE451330B (fr)
YU (1) YU41354B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4601904A (en) * 1983-03-10 1986-07-22 E. R. Squibb & Sons, Inc. Antibiotics xylocandin A and xylocandin B
JPH0538645Y2 (fr) * 1986-08-19 1993-09-30
JPH0333284Y2 (fr) * 1986-09-08 1991-07-15
JPH0667948B2 (ja) * 1986-12-23 1994-08-31 花王株式会社 抗生物質ｙｉ−ｈｕ３及びその製造法
WO2001012831A2 (fr) * 1999-08-17 2001-02-22 Ut-Battelle, Llc Compositions antibacteriennes et antivirales et procedes y relatifs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL169615C (nl) * 1969-06-18 1982-08-02 Merck & Co Inc Werkwijze ter bereiding van een antibioticum en werkwijze ter bereiding van een farmaceutisch preparaat met anti-bacteriele en anti-tumoractiviteit.
JPS4843841B1 (fr) * 1969-09-06 1973-12-21
JPS50135292A (fr) * 1974-04-17 1975-10-27
US4051237A (en) * 1975-08-28 1977-09-27 Bristol-Myers Company Glycopeptide antibiotics bu-2231 a and b and process for producing same
JPS5231891A (en) * 1975-09-03 1977-03-10 Hitachi Chem Co Ltd Method of manufacturing novel anti-tumor antibiotics, vi-7501
JPS52105292A (en) * 1976-02-27 1977-09-03 Meiji Seika Kaisha Ltd Preparation of novel antibiotic bn-183
JPS595278B2 (ja) * 1976-07-10 1984-02-03 北里研究所（社団法人） 新規抗生物質ｐｏ−３５７物質及びその製造法並びに用途

Also Published As

Publication number Publication date
FR2445339B1 (fr) 1983-09-02
JPS6110119B2 (fr) 1986-03-28
IL58964A (en) 1982-09-30
US4283389A (en) 1981-08-11
CA1133409A (fr) 1982-10-12
GB2039881A (en) 1980-08-20
JPS55102596A (en) 1980-08-05
CH642397A5 (fr) 1984-04-13
FR2445339A1 (fr) 1980-07-25
NL7909242A (nl) 1980-07-01
BE880850A (fr) 1980-04-16
YU41354B (en) 1987-02-28
ES8104400A1 (es) 1981-04-01
IT7951182A0 (it) 1979-12-24
NL178265C (nl) 1986-02-17
DE2950980C2 (de) 1984-08-23
GB2039881B (en) 1983-05-05
NL178265B (nl) 1985-09-16
ES487313A0 (es) 1981-04-01
IT1162430B (it) 1987-04-01
SE7910626L (sv) 1980-06-28
IL58964A0 (en) 1980-03-31
DE2950980A1 (de) 1980-07-03

Similar Documents

Publication Publication Date Title
EP0182315B1 (fr) Antibiotique NK84-0218, compositions pharmaceutiques le contenant et procédé pour sa production
KR960013432B1 (ko) 항균제 fr109615 및 이의 제조방법
US3923977A (en) Antibiotic FR-1923 substance
SE451330B (sv) Farmaceutisk komposition innefattande en antibiotisk substans benemnd bn-183b vilken er framstelld genom odling av pseudomonas sp bn-183 (ferm-p 3332,atcc 31571)
US4536398A (en) Antiviral agents
US4143135A (en) Antibiotic phosphonic acid derivatives and production and use thereof
KOMORI et al. LAVENDOMYCIN, A NEW ANTIBIOTIC I. TAXONOMY, ISOLATION AND CHARACTERIZATION
GB2069500A (en) Antibiotic actinomadura l-31 a,b
HU181721B (en) Process for preparing antibiotics c-19393sdown 2 and c-1939hdown 2
US4016260A (en) Novel polypeptide produced by pseudomonas
EP0055299B1 (fr) Antibiotique y-16482 alpha et/ou antibiotique y-16482 beta, leur prodece de preparation; et composition medicinale les contenant
EP0236110A2 (fr) Agents de croissance pour animaux
US4552867A (en) Antibiotic LL-BO1208α and LL-BO1208β, process of preparation, pharmaceutical composition and method of use
USRE29903E (en) Antibacterial antibiotics AM31α, AM31β and AM31γ
Ezaki et al. BN-183B, A NEW ANTITUMOR ANTIBIOTIC PRODUCED BY PSEUDOMONAS TAXONOMY, ISOLATION, PHYSICO-CHEMICAL AND BIOLOGICAL PROPERTIES
EP0144238B1 (fr) Composé FR-900451, sa production et son emploi
US3655876A (en) Antibiotic cp-21 635
US4298599A (en) Novel antibiotic BN-235 substance, and process for the production thereof
EP0142121B1 (fr) Substances dénommées WS 7739, leur préparation et composition pharmaceutique les contenant
HU194310B (en) Process for preparing alkali metal, alkali earth metal, ammonium salt and n-deacetylated derivative of novel tan-588 antibiotic
US4650765A (en) Biologically pure culture of Streptoverticillium stramineum sp. nov.
US3155583A (en) Antibiotic narangomycin and method of production
EP0025713B1 (fr) Antibiotique de la série de l'anthracycline et composition pharmaceutique le contenant
US4667027A (en) Cephem compounds and their production
US4235883A (en) Novel antibiotic BN-213 substance and its production

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7910626-6

Format of ref document f/p: F